Target intelligence / Profile preview

RGS2 antisense RNA 1 (RGS2-AS1)

Target
RGS2-AS1
Molecular classification
Long intergenic non-coding RNA (lincRNA), Antisense RNA, Long non-coding RNA (lncRNA)
01

Overview

RGS2 antisense RNA 1 (RGS2-AS1), also known as LINC01032 or long intergenic non-protein coding RNA 1032, is a human long intergenic non-coding RNA (lincRNA). It is annotated as a non-protein-coding transcript located near or overlapping the RGS2 gene in antisense orientation. Like other lincRNAs and antisense RNAs, RGS2-AS1 is presumed to play roles in gene regulation, such as modulating expression of its neighboring sense gene(s) through epigenetic or transcriptional mechanisms. lincRNAs and antisense RNAs are increasingly recognized for their diverse molecular activities, including chromatin modification, RNA stabilization, transcriptional regulation, and potentially acting as molecular scaffolds for chromatin and RNA-binding proteins. However, the precise biological functions and any involvement in human disease for RGS2-AS1 specifically remain uncharacterized in published literature as of the search date. No approved or investigational drugs are known to specifically target RGS2-AS1, nor is it an established biomarker for disease or therapy response at this time.

Other names
LINC01032Long intergenic non-protein coding RNA 1032RGS2-AS1
02

Biological functions

Gene expression regulationChromatin remodelingTranscriptional regulation
03

Disease associations

Other

Beyond the preview

Go deeper on RGS2 antisense RNA 1 (RGS2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RGS2 antisense RNA 1 (RGS2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call